Calcific aortic stenosis: an update
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Calcific aortic stenosis in the elderly is the number one cause of surgical valve replacement in the US and Europe. The incidence of calcific aortic stenosis is increasing as the general age of the population increases. For many years, rheumatic heart disease was the main cause of aortic valve disease. Over the last half century, however, there has been a change from a rheumatic etiology to a 'degenerative' mechanism because of the increase in access to health care in developed countries and the increasing age of the population in the US and Europe. For many years 'degenerative' aortic stenosis was thought to be caused by the passive accumulation of calcium on the surface of the aortic valve leaflet. Recent studies have demonstrated, however, that the etiology of aortic valve disease has a similar pathophysiology to that of vascular atherosclerosis, and that the treatment of this disease could be similar to that of chronic vascular atherosclerosis. This Review will discuss our current understanding of the pathophysiology, risk factors, cellular mechanisms, diagnosis and finally, future medical therapies for calcific aortic stenosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pathobiology of calcific AS is complex and involves genetic factors, lipoprotein deposition and oxidation, chronic inflammation, osteoblastic transition of cardiac valve interstitial cells and active leaflet calcification”
From Calcific aortic stenosis (2016) · cites this paper as [23]
In the citing paper
“Now, there is compelling histopathologic and clinical data suggesting that calcific valve disease is, in fact, an active and multifaceted condition involving lipoprotein deposition, chronic inflammation, osteoblastic transition of valve interstitial cells and active leaflet calcification2223.”
From Calcific aortic stenosis (2016) · cites this paper as [23]
Citations
Cites
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Self-citationClinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
Mutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509 · cited 1×
“These studies have identified polymorphisms in genes including NOTCH1 (homologous to the Drosophila Notch gene that regulates cell fate decisions during development), the vitamin D receptor gene, and the apolipoprotein E2 allele”
BackgroundPredictors of Outcome in Severe, Asymptomatic Aortic Stenosis
Rosenhek, R., Binder, T., Porenta, G., Lang, I., Christ, G., Schemper, M., Maurer, G., & Baumgartner, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430903 · Cited by 1,338
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315
Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly
Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J., & Siscovick, D. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410302 · Cited by 1,283 · cited 1×
“Permission obtained from Lippincott Williams & Wilkins © Freeman RV and Otto CM (2005) Circulation 111: 3316–3326.”
MethodRahimtoola, S. H. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90685-6 · Cited by 1,257
Self-citationLindroos, M., Kupari, M., Heikkilä, J., & Tilvis, R. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90249-z · Cited by 1,160
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
Cowell, S. J., Newby, D. E., Prescott, R. J., Bloomfield, P., Reid, J., Northridge, D. B., & Boon, N. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043876 · Cited by 1,146 · cited 1×
“The Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) was the first prospective study to test the effect of statin therapy on this disease process”
BackgroundBone Formation and Inflammation in Cardiac Valves
Mohler, E. R., Gannon, F., Reynolds, C., Zimmerman, R., Keane, M. G., & Kaplan, F. S. (2001) · Circulation · doi:10.1161/01.cir.103.11.1522 · Cited by 1,049 · cited 1×
“Experimental in vivo and ex vivo models have demonstrated the critical features of aortic valve calcification, which include osteoblast expression, cell proliferation and atherosclerosis”
Background
Research works printed but not linked: 1
- Ross J Jr and Braunwald E (1968) Aortic stenosis. Circulation 38 (Suppl 1): S61–S67
Cited by
Items 101–174 of 174
Morany, A., Lavon, K., Halevi, R., Haj-Ali, N., Bluestein, D., Raanani, E., Hamdan, A., & Haj-Ali, R. M. (2022) · Annals of Biomedical Engineering · doi:10.1007/s10439-022-03115-8 · Cited by 6
Understanding the Molecular and Cellular Changes Behind Aortic Valve Stenosis
Falcão‐Pires, I., Gavina, C., & Leite-Moreira, A. F. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011208062485 · Cited by 7
Conte, M., Poggio, P., Monti, M., Petraglia, L., Cabaro, S., Bruzzese, D., Comentale, G., Caruso, A., Grimaldi, M., Zampella, E., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021171 · Cited by 7
Risk factor profile of calcific aortic stenosis
Sathyamurthy, I., Alex, S., Kirubakaran, K., Sengottuvelu, G., & Srinivasan, K. N. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.04.007 · Cited by 12
A Decade of Transcatheter Aortic Valve Implantation in New Zealand: Growth and Inequalities
Wong, B., Armstrong, G., El‐Jack, S., & To, A. C. Y. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.08.025 · Cited by 10
Corbacho-Alonso, N., Sastre-Oliva, T., Lopez-Almodovar, L. F., Solís, J., Padial, L. R., Tejerina, T., Carrascal, M., Mouriño-Álvarez, L., & Barderas, M. G. (2023) · Translational research · doi:10.1016/j.trsl.2023.04.002 · Cited by 6
Lu, W., Sun, C., & Hou, J. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-72 · Cited by 6
Neurologic complications of valvular heart disease
Cruz‐Flores, S. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4086-3.00006-0 · Cited by 6
Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure
Makarović, S., Makarović, Z., Bilić-Ćurčić, I., Milas-Ahić, J., Mihaljević, I., Franceschi, M., & Jukić, T. (2017) · Acta Clinica Croatica · doi:10.20471/acc.2017.56.04.22 · Cited by 8
Fojt, R., Pirk, J., Kamenický, P., Karpíšek, M., Straka, Z., Malý, M., & Motovska, Z. J. (2015) · Cardiovascular Pathology · doi:10.1016/j.carpath.2015.12.003 · Cited by 5
Al‐Kassou, B., Al‐Kassou, L., Mahn, T., Lütjohann, D., Shamekhi, J., Willemsen, N., Niepmann, S. T., Baldus, S. E., Kelm, M., Nickenig, G., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031997 · Cited by 4
“In fact, histopathological examination of resected human aortic valves has revealed that calcific aortic valve cusps abundantly contain CC. 12,13 Moreover, it has been demonstrated that CCs can activate the NLRP3 (NOD-like receptor protein 3) inflammasome in macrophages, resulting in an interleukin-1 driven inflammati…”
Review: Does lowering cholesterol have an impact on the progression of aortic stenosis?
Greve, A. M., & Wachtell, K. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708093935 · Cited by 4
“…how inflammation and endothelial dysfunction is initiated, sustained, and how it plays together with other features, such as angiogenesis, calcification, and fibrosis, observed in calcific AS. [Kuiper et al. 2007; Rajamannan et al. 2007; Mazzone et al. 2006; O’Brien, 2006; Mohler, III, 2004].”
BackgroundBordalo, Á. D. B., Nobre, Â. L., Dantas, M., & Cravino, J. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2012.04.017 · Cited by 5
Inpatient Outcomes of Gastric Antral Vascular Ectasia in Those With Aortic Stenosis
Aldiabat, M., Kilani, Y., Alahmad, M., Alhuneafat, L., Aljabiri, Y., Horoub, A., Alabdallah, K., Alrahamneh, H., & Manvar, A. (2023) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001932 · Cited by 4
Tam, D. Y., & Sadri, H. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.06.005 · Cited by 6
Hjortnaes, J., & Aikaw, E. (2011) · InTech eBooks · doi:10.5772/20179 · Cited by 6
“The extent to which the mechanism of CAVD is similar to that of atherosclerosis remains unclear (Mohler, 2004, Rajamannan et al, 2007).”
Natural Progression of Low-Gradient Severe Aortic Stenosis with Preserved Ejection Fraction
Innasimuthu, A. L., Kumar, S., Lazar, J., & Katz, W. E. (2014) · Texas Heart Institute Journal · doi:10.14503/thij-13-3167 · Cited by 6
“I n the western world, aortic stenosis (AS) is the most prevalent valvular heart disease and the 3rd most prevalent cardiovascular disease, after hypertension and coronary artery disease.(1) The prevalence of AS increases with age, from 2% of adults older than 65 years to 4% of adults older than 85.”
BackgroundThe role of echocardiography in the evaluation and management of aortic stenosis in the older adult
Hage, F. G., Adegunsoye, A., Mundkur, M. L., & Nanda, N. C. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.080 · Cited by 3
“Calcific AS is the most common indication for valve replacement surgery, and the second most common indication for cardiac surgery, after coronary artery bypass grafting, in older adults [3].”
BackgroundCardiovascular oxidative stress: recent findings on ACE2 And MAO
Silva, R. A. P. (2012) · doi:10.17077/etd.109quuf9 · Cited by 3
Association between evolocumab use and slow progression of aortic valve stenosis
Terasaka, K., Gohbara, M., Abe, T., Yoshii, T., Hanajima, Y., Kirigaya, J., Horii, M., Kikuchi, S., Nakahashi, H., Matsushita, K., et al. (2024) · Heart and Vessels · doi:10.1007/s00380-024-02386-6 · Cited by 2
“Previous trials reported that serum LDL-C levels are associated with AS progression [19, 20].”
Iacobucci, I., Monaco, V., Lobianco, A. L., Cipolletta, B., Birolo, L., Conte, M., Myasoedova, V. A., Valerio, V., Poggio, P., Parisi, V., et al. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01499-0 · Cited by 3
“Over time, fibrosis, inflammation, oxidative stress, angiogenesis, and osteogenic differentiation contribute to the progressive remodeling of the aortic valve leaflets (Rajamannan et al. 2007; Freeman and Otto 2005).”
Neurologic complications of nonrheumatic valvular heart disease
Cruz‐Flores, S. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00003-2 · Cited by 2
Bordalo, Á. D. B., Nobre, Â. L., Dantas, M., & Cravino, J. (2012) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2011.12.018 · Cited by 5
Slowing the progression of aortic stenosis
Maganti, K., & Rajamannan, N. M. (2008) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-008-0003-3 · Cited by 3
Self-citationLokuskipti vegna ósæðarlokuþrengsla á Íslandi 2002-2006: Langtímafylgikvillar og lifun
Viktorsson, S. A., Ingvarsdóttir, I. L., Hreinsson, K., Sigurdsson, M. I., Helgadóttir, S., Arnórsson, Þ., Daníelsen, R., Guðbjartsson, T., & Guðbjartsson, T. (2011) · Læknablaðið · doi:10.17992/lbl.2011.11.395 · Cited by 2
HEART AND AGE (PART II): CLINICAL MANIFESTATIONS OF AGEING
Akasheva, D. U., Владимировна, П. Е., Strazhesko, I. D., Dudinskaya, Е. N., & Tkacheva, O. N. (2013) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2013-4-86-90 · Cited by 3
Houessou, U., Zamani, P., Manikpurage, H. D., Li, Z., Gaudreault, N., Dahmene, M., Dagenais, F., Couture, C., Clavel, M.-A., Pibarot, P., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120791 · Cited by 1
Assessment of remote digital auscultation for identifying significant aortic stenosis: A pilot study
Avidan, Y., Tabachnikov, V., & Aker, A. (2025) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2025.06.072 · Cited by 1
Courtney, W., Walker, J. A., Dorai-Raj, A., Arnous, S., O’Connor, C. T., Playford, D. A., Ihdayhid, A. R., Schultz, C. J., Hillis, G. S., & Kiernan, T. J. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2652411 · Cited by 1
Valvular heart disease in women
Maganti, K., Rigolin, V. H., & Bonow, R. O. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0041-0 · Cited by 1
Self-citationFDG-PET-CT as a Biomarker for Aortic Valve Inflammation
Gurm, G. S., & Tawakol, A. A. (2011) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-011-9117-1 · Cited by 1
“Aortic stenosis (AS) is the most common valvular disease in United States, accounting for approximately 1 billion dollars in health care expenditure annually [1, 2].”
BackgroundNaicker, A., Brown, S. C., & Ponnusamy, S. (2017) · SA Heart · doi:10.24170/13-4-1582 · Cited by 2
Gorges, R. D., Burke, P., David, W. S., Cole, A., McCullough, P. A., & David, S. W. (2011) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0594 · Cited by 1
Cardiovascular oxidative stress: recent findin gs on ACE2 And MAO
Alfonso, R. M., & Silva, P. (2012) · Cited by 1
Modeling Biomechanics in the Healthy and Diseased Heart
Miller, R., Marlevi, D., Zhang, W., Hirschvogel, M., Hadjicharalambous, M., Capilnasiu, A., Balmus, M., Hager, S., Jilberto, J., Bonini, M., et al. (2021) · Nečas center series · doi:10.1007/978-3-030-88084-2_5 · Cited by 1
Ortiz‐Prado, E., Ojeda, O. R., & Silva, F. J. (2008) · Revista Ecuatoriana de Neurologia
Donate‐Correa, J., Martínez‐Sanz, R., Muros‐de‐Fuentes, M., Fernández, C. M., Martín‐Núñez, E., Cazaña‐Perez, V., de-la-Llana, R., & Navarro‐González, J. F. (2013)
Fairbairn, T. A. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Evaluation and management of aortic valve and root disease
deGraft-Johnson, J., & Gleason, T. G. (2007) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-007-0041-2
Chondromodulin-I maintains normal cardiac valves by preventing angiogensis
Hakuno, D., Kimura, N., Yoshioka, M., & Fukuda, K. (2007) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2007.09.007
Chen, W., Leiyang, Z., Fei, D., Yifan, Z., Xiao, R., Li, L., Zou, L., Ganggang, M., Lu, Z., & Chen, X. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.02.011 · Cited by 2
“Degenerative aortic valve calcification (DAVC) is an important cause of aortic valve stenosis and incompetence, which can lead to heart failure [1].”
BackgroundEffect of valve replacement for aortic stenosis on ventricular function
Zhao, Y. X. (2011) · DiVA at Umeå University (Umeå University) · Cited by 1
Characterization of aortic valve stenosis by mathematical modelling of the reflectance spectroscopy
Rodrigues, K. C., Zângaro, R. A., Andrade, A. D. O., & Magini, M. (2012) · Journal of Biomedical Graphics and Computing · doi:10.5430/jbgc.v2n2p48
Zhao, Y. X., & He, Y. (2015) · International Cardiovascular Forum Journal · doi:10.17987/icfj.v1i1.9
Valvular interstitial cell transformation : implications for aortic valve calcification
Boroomand, S. (2014) · cIRcle (University of British Columbia) · doi:10.14288/1.0167517
Osteocardiology: Endochondral Bone Formation
Rajamannan, N. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64994-8_5
Self-citationThe Differential Meaning of LV and LA Strains in Aortic Valve Stenosis: A Feature Tracking MRI Study
Lamy, J., Soulat, G., Evin, M. A., Bouazizi, K., Giron, A., Redheuil, A. B., Mousseaux, É., & Kachenoura, N. (2017) · Computing in cardiology · doi:10.22489/cinc.2017.191-279
“Aortic valve stenosis (AVS) is the most common valve disease in industrialized countries and its prevalence is unceasingly increasing with populations aging [1, 2].”
BackgroundImproving HDL Functions - A New Version of The Quest of SANCGREAL?
Bordalo, Á. D. B. (2018) · Journal of Cardiology and Cardiovascular Sciences · doi:10.29245/2578-3025/2018/2.1116
Balloon aortic valvuloplasty of severe aortic stenosis in the era of TAVR
Kogoj, P., Furlan, T., & Bunc, M. (2014) · Srce i krvni sudovi · doi:10.5937/siks1401021k
Ferrari, G. M., & Grau, J. B. (2019) · Springer eBooks · doi:10.1007/978-3-7091-4874-7_41
Valvular Heart Disease: Pathological Anatomy and Pathogenesis
Buja, L. M. (2019) · Cardiovascular medicine · doi:10.1007/978-1-4471-2840-3_1
Differential Mechanisms of Arterial and Valvular Calcification
Rogers, M. A., & Aïkawa, E. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-46725-8_4
MORPHOMETRIC STUDY OF HUMAN AORTIC VALVE IN ADULTS OF WESTERN MAHARASHTRA: A CADAVERIC STUDY
Nitin, G., Subhash, B., & Kumar, S. (2020) · International Journal of Medical and Biomedical Studies · doi:10.32553/ijmbs.v4i7.1309
Influencing factors of aortic valve disease progression after mitral valve surgeryPreprint
Sun, Z., Liang, Y., Li, S., Li, H., Yuan, Y., Zou, X., & Yan, Y.-S. (2020) · doi:10.22541/au.159986459.97211431
Aitaliyev, S., Rumbinaitė, E., Nekrošius, R., Keturakis, V., & Benetis, R. (2021) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/11039
“AS is a fibrocalcific fusion of leaflets due to the progression of fibrosis and leaflet calcification [14, 15].”
Ruzicka, D. J., Hettich, I. M., Eichinger, E., & Lange, R. (2008) · Springer eBooks · doi:10.1007/978-3-540-74925-7_48
Ruzicka, D. J., Hettich, I. M., Eichinger, W. B., & Lange, R. (2009) · Springer eBooks · doi:10.1007/978-3-540-93936-8_60
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-26011-4.09965-4 · Cited by 1
Vaideeswar, P., Singaravel, S., & BUTANY, J. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00008-6
Response to the “Glasgow Prognostic Score as A Marker of Mortality After TAVI”
Büber, İ. (2022) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2021-0577
“Aortic stenosis is one of the most common valve diseases in the worldwide population[2], and the increase in the elderly population increases the frequency of TAVI, which is a wellestablished alternative to surgical valve replacement in patients at high surgical risk[3].”
BackgroundVeerapudran, S., Damodaran, D., Pillai, V. V., Natarajan, G., Pillai, P. T. K., & Karunakaran, J. (2023) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-022-01468-2
Pre‐procedural nursing home length of stay and outcomes of transcatheter aortic valve replacement
Nicely, P., Yang, L., Kim, D. H., & Berry, S. D. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19124
Bibliometric analysis of treatment modalities in calcific aortic valve stenosis
Yang, H., Yang, Y.-J., Wang, Z., & Tang, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1431311 · Cited by 2
“Over the past two decades, our understanding of CAVS has signi fi cantly evolved, challenging the long-standing belief that it is merely a degenerative condition (Otto, 2008; Rajamannan et al., 2007; Yip and Simmons, 2011).”
Genetics of Valvular Heart Disease
Knoll, K., & Trenkwalder, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00033-9
Hussain, A., Dar, M. N. R., Arif, A. M., & Malik, M. Y. (2025) · Chinese Journal of Physics · doi:10.1016/j.cjph.2025.09.017
Adipocytes in Aortic Stenosis: Association With Clinical and Morphological Indices
Zoico, E., Saatchi, T., Urbani, S., Rizzatti, V., Mazzali, G., Fantin, F., Faccioli, S., Gavras, A., Zamboni, M. M., & Giani, A. (2025) · Clinical Anatomy · doi:10.1002/ca.70045
“This condition is marked by progressive thickening and calcification of the aortic valve cusps, leading to sclerosis and advanced valve dysfunction with associated inflammatory, atherogenic, and osteogenic changes (Freeman and Otto 2005; Rajamannan et al. 2007).”
Amyloids here, amyloids there…What’s wrong with them?
Gharibyan, A. L. (2012) · DiVA at Umeå University (Umeå University)
Survival and functional recovery following valve replacement in patients with severe aortic stenosis
Ding, W. (2013) · DiVA (Digitala Vetenskapliga Arkivet)
Déterminants de la progression et de la réponse myocardique dans le rétrécissement aortique calcifié
Arangalage, D. (2018) · theses.fr (ABES) · doi:10.70675/cc101f7dz401ez4bc1zb308za377e4500f20
Byczkowski, J., Chierchia, G., Muscogiuri, G., Sciatti, E., Severi, F., Sienkiewicz, K., Bonaffini, P. A., Fijałkowska, J., Szurowska, E., Licu, R.-A., et al. (2026) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000904
CT-Based Annular Measurements as a Predictor for Perceval Valve Size Selection
Ramchandani, M. K., Arzt, S., Hiraoka, A., Mićović, S., Niinami, H., Fischlein, T. J. M., Moten, S., Wang, J., Kent, W., Savini, C., et al. (2026) · Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery · doi:10.1177/15569845261472983
Assessment of Aortic Stenosis Severity: Determining Timing to Surgery
Pîbarot, P., & Dumesnil, J. G. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4132-7_8
Metadata
- Authors
- Rajamannan, N. M., Bonow, R. O., & Rahimtoola, S. H.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Rahimtoola, Shahbudin H
- Venue
- Nature Clinical Practice Cardiovascular Medicine
- Published
- 2007-05
- Volume
- 4
- Issue
- 5
- Pages
- 254-262
- ISSN
- 1743-4297 (ISSN-L)
- 1743-4300
- OpenAlex
- W2028139616
- Cited by
- 176
- References
- 64
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 10 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 9 · 2015: 6 · 2014: 9 · 2013: 14 · 2012: 14
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Cardiovascular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Keywords
- calcific aortic stenosis, aortic valve disease, pathophysiology, rheumatic heart disease, calcium deposition, risk factors, diagnosis, medical therapy, valve replacement, older adults
- MeSH terms
- Age Factors, Aortic Valve Stenosis, Calcinosis, Calcium, Diagnosis, Differential, Echocardiography, Europe, Heart Ventricles, Humans, Myocardium, Prognosis, Stroke Volume, United States, Incidence, Survival Rate, Disease Progression, Heart Valve Prosthesis Implantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.